我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
13
0 进行中
药物批准
2
批准总数
监管机构
1
监管机构数
成立时间
N/A
已完成
100.0%
FDA
Food and Drug Administration
- Charles "Chuck" Leitgeb, Deputy Director of State Government Relations at Bayer US, was elected Chair of the HINJ Board of Trustees, effective July 1, 2026. - Adam Brand of Otsuka America Pharmaceutical was elected Vice Chair, with Christopher Guiton (Johnson & Johnson) as Treasurer and Derek Naten (Keenova Therapeutics) as Secretary. - Adam Taliaferro of Johnson & Johnson was reappointed Chair of the HINJ Steering Committee, with George Coutros of Sanofi US reappointed as Vice Chair. - The board includes senior government affairs leaders from major pharmaceutical companies including Novo Nordisk, Merck, BD, Novartis, and Daiichi Sankyo.
